Active Ingredient: OLAPARIB
Proprietary Name: LYNPARZA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N206162
Product Number: 001
Approval Date: Dec 19, 2014
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Discontinued
Patent and Exclusivity Information
